Drug profile · INN
ledispavir
HARVONI
ledispavir (HARVONI) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J05) J05AX65
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ledispavir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
ledispavir (HARVONI) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN ledispavir
Brand HARVONI
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AX65
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ledispavir?
ledispavir (HARVONI) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for ledispavir?
HARVONI is a marketed brand name for ledispavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.